Abbott Toxicology Icup Dx Pro 2

The iCup Dx Pro 2 is a multi-panel device designed to screen for seven distinct substance groups using an integrated cup format. This test is suitable for CLIA Waived testing environments.

The comprehensive panel includes:

• AMP (Amphetamine)
• BZO (Benzodiazepines)
• BUP (Buprenorphine)
• COC (Cocaine)
• OPI 300 (Opiates, tested at a 300 ng/mL cutoff)
• OXY (Oxycodone)
• THC (Marijuana/Tetrahydrocannabinol), which reports results for Cutoff (CR), Screening (SG), and Oxidation (OX).

Yes, the Abbott Toxicology Icup Dx Pro 2 is CLIA Waived.

This status confirms the test is classified as simple and low-risk, making it appropriate for use in facilities operating under the Clinical Laboratory Improvement Amendments (CLIA) waiver requirements. This simplifies the testing protocols for point-of-care drug screening in professional, clinical, or occupational settings.

Each box of the Abbott Toxicology Icup Dx Pro 2 is supplied with 25 individual drug test cups. This quantity provides a practical configuration for high-volume use in professional medical, clinical, or occupational testing settings.

Yes, the Abbott Toxicology iCup Dx Pro 2 is specifically designed for professional medical, clinical, or occupational testing environments.

This diagnostic device facilitates rapid drug screening and is notable for its:

• Regulatory Status: It is CLIA Waived, making it suitable for point-of-care use in facilities meeting CLIA waiver requirements.
• Testing Format: It utilizes the highly convenient, integrated iCUP format.
• Multi-Panel Screening: The cup screens for seven substance groups: Amphetamine (AMP), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Opiates 300 ng/mL (OPI 300), Oxycodone (OXY), and Marijuana (THC).

The Abbott Toxicology iCup Dx Pro 2 detects a comprehensive panel of drugs and drug metabolites in urine, including AMP, BZO, BUP, COC, OPI 300, OXY, and THC. The “CR/SG/OX” associated with THC indicates the test also assesses for Creatinine, Specific Gravity, and Oxidants to help ensure sample integrity.

The Abbott Toxicology iCup Dx Pro 2 detects Opiates (OPI) with a cutoff level of 300 ng/mL, indicated by “OPI 300” in its specifications.

The Abbott Toxicology Icup Dx Pro 2 utilizes the iCUP format.

This integrated cup testing methodology offers significant convenience and efficiency for point-of-care drug screening, as it allows for:

• Rapid collection: The urine sample is collected directly into the testing device.
• Integrated testing: The testing panels are built into the cup, streamlining the process.
• Efficiency: Optimized for rapid protocols in professional medical, clinical, or occupational testing environments.

The Abbott Toxicology Icup Dx Pro 2 uses the integrated cup (iCUP) format which is specifically designed to maximize convenience and efficiency during point-of-care testing. This integrated design offers several benefits:

• Ease of Use: It combines the collection cup and testing device into one unit.
• Streamlined Process: It minimizes sample handling and potential exposure.
• Optimized for Speed: The system facilitates rapid detection protocols, making it ideal for CLIA-waived environments.

The Abbott Toxicology iCUP Dx Pro 2 is designed to screen for a comprehensive range of substances, including:

• AMP (Amphetamines)
• BZO (Benzodiazepines)
• BUP (Buprenorphine)
• COC (Cocaine)
• OPI 300 (Opiates)
• OXY (Oxycodone)
• THC (Marijuana)

Each box of the Abbott Toxicology Icup Dx Pro 2 includes 25 individual drug test cups.